CD1D Antibodies

Santa Cruz Biotechnology offers a broad range of CD1D monoclonal antibodies for research focused on understanding CD1D's role in immune responses. CD1D monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD1D is a crucial protein involved in the presentation of lipid antigens to T cells, playing a significant role in the regulation of immune responses and the activation of natural killer T (NKT) cells. CD1D's importance in immune surveillance has been demonstrated through extensive research in autoimmune diseases and cancer development. Understanding CD1D function can provide valuable insights into therapeutic strategies for modulating immune responses. Researchers worldwide rely on CD1D monoclonal antibodies to advance their understanding of immune system regulation. CD1D research continues to reveal new pathways and mechanisms in immunology, opening doors to innovative therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies for CD1D research support scientists in their mission to advance immunological discoveries and develop new therapeutic strategies.